CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML...
Phase 3
Seville, Andalusia, Spain and 114 other locations
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Acute myeloid leukemia...
Phase 2, Phase 3
Seville, Sevilla, Spain and 34 other locations
will be evaluated in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML). The main study has ...
Phase 1, Phase 2
Seville, Spain and 43 other locations
The purpose of this study is to assess if adding revumenib to standard chemotherapy improves outcomes in participants with AML with certain ...
Phase 3
Seville, Spain and 148 other locations
and Venetoclax in participants with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndro...
Phase 1
Seville, Spain and 15 other locations
VEN+AZA alone for the treatment of participants with newly diagnosed Acute Myeloid Leukemia (AML) with a mutation...
Phase 3
Seville, Spain and 265 other locations
of JNJ-90189892 in participants with relapsed or refractory (R/R) acute myeloid leukemia (AML) or R/R higher-risk...
Phase 1
Seville, Spain and 8 other locations
combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...
Phase 3
Seville, Spain and 285 other locations
administered in combination with venetoclax to adult patients with acute myeloid leukemia (AML) who are relapsed ...
Phase 2
Seville, Spain and 36 other locations
monotherapy and in combination with azacitidine in participants with acute myeloid leukemia (AML) and myelodyspla...
Phase 1, Phase 2
Seville, Spain and 48 other locations
Clinical trials
Research sites
Resources
Legal